Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127060142 | 12706014 | 2 | F | 20160425 | 20160901 | 20160901 | PER | US-JAZZ-2016-US-007714 | JAZZ | 0.00 | M | Y | 0.00000 | 20160901 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127060142 | 12706014 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 21196 | 3 | G | ORAL SOLUTION | |||||||
127060142 | 12706014 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | 21196 | ORAL SOLUTION | |||||||||
127060142 | 12706014 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | 21196 | 4.5 | G | ORAL SOLUTION | |||||||
127060142 | 12706014 | 4 | SS | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | UNK | 0 | |||||||||||
127060142 | 12706014 | 5 | C | SUBOXONE | BUPRENORPHINE HYDROCHLORIDENALOXONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
127060142 | 12706014 | 6 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | U | 0 | |||||||||||
127060142 | 12706014 | 7 | C | ARICEPT | DONEPEZIL HYDROCHLORIDE | 1 | U | 0 | |||||||||||
127060142 | 12706014 | 8 | C | BIAXIN | CLARITHROMYCIN | 1 | U | 0 | |||||||||||
127060142 | 12706014 | 9 | C | JALYN | DUTASTERIDETAMSULOSIN HYDROCHLORIDE | 1 | U | 0 | |||||||||||
127060142 | 12706014 | 10 | C | Metformin hcl | METFORMIN HYDROCHLORIDE | 1 | U | 0 | |||||||||||
127060142 | 12706014 | 11 | C | NEURONTIN | GABAPENTIN | 1 | U | 0 | |||||||||||
127060142 | 12706014 | 12 | C | NUVIGIL | ARMODAFINIL | 1 | U | 0 | |||||||||||
127060142 | 12706014 | 13 | C | RAMIPRIL. | RAMIPRIL | 1 | U | 0 | |||||||||||
127060142 | 12706014 | 14 | C | SIMVASTATIN. | SIMVASTATIN | 1 | U | 0 | |||||||||||
127060142 | 12706014 | 15 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | U | 0 | |||||||||||
127060142 | 12706014 | 16 | C | Terbinafine Hcl | TERBINAFINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
127060142 | 12706014 | 17 | C | TESTOSTERONE CYPIONATE. | TESTOSTERONE CYPIONATE | 1 | U | 0 | |||||||||||
127060142 | 12706014 | 18 | C | WELLBUTRIN XL | BUPROPION HYDROCHLORIDE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127060142 | 12706014 | 1 | Narcolepsy |
127060142 | 12706014 | 4 | Sinusitis |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127060142 | 12706014 | Diarrhoea | |
127060142 | 12706014 | Ear pain | |
127060142 | 12706014 | Pain in jaw | |
127060142 | 12706014 | Sinusitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127060142 | 12706014 | 1 | 200508 | 200509 | 0 | |
127060142 | 12706014 | 3 | 200801 | 0 |